30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Nexvet Biopharma plc (NVET)

Track

Stock chart
Ticker: NVET Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GEARING DAVID
CHIEF SCIENTIFIC OFFICER
1 purchase — total 30,150 USD
Buy 4 Mar 2016
Value US$1,317,650.33 | Price 322.37 | Shares 9,966
Sale 3 Mar 2016
Value US$4,818,670.83 | Price 367.87 | Shares 50,917
Buy 3 Mar 2016
Value US$6,888.38 | Price 3.26 | Shares 2,113
Buy 2 Mar 2016
Value US$4,800.00 | Price 3.20 | Shares 1,500
Buy 26 Feb 2016
Value US$40,500.84 | Price 3.34 | Shares 12,126
Buy 26 Feb 2016
Value US$32,101.44 | Price 3.36 | Shares 9,554
Buy 26 Feb 2016
Value US$25,058.88 | Price 3.36 | Shares 7,458
Buy 26 Feb 2016
Value US$2,540.16 | Price 3.36 | Shares 756
Buy 26 Feb 2016
Value US$3,024.00 | Price 3.36 | Shares 900
Buy 26 Feb 2016
Value US$1,478.40 | Price 3.36 | Shares 440
Buy 26 Feb 2016
Value US$11,098.08 | Price 3.36 | Shares 3,303
Buy 26 Feb 2016
Value US$10,899.84 | Price 3.36 | Shares 3,244
Buy 26 Feb 2016
Value US$10,103.52 | Price 3.36 | Shares 3,007
Buy 25 Feb 2016
Value US$62,700.00 | Price 3.30 | Shares 19,000
Buy 25 Feb 2016
Value US$208,906.92 | Price 3.18 | Shares 65,694
Buy 25 Feb 2016
Value US$163,079.94 | Price 3.18 | Shares 51,283
Buy 25 Feb 2016
Value US$16,529.64 | Price 3.18 | Shares 5,198
Buy 25 Feb 2016
Value US$19,674.66 | Price 3.18 | Shares 6,187
Buy 25 Feb 2016
Value US$9,622.68 | Price 3.18 | Shares 3,026
Buy 25 Feb 2016
Value US$72,217.80 | Price 3.18 | Shares 22,710
Buy 25 Feb 2016
Value US$70,926.72 | Price 3.18 | Shares 22,304
Buy 25 Feb 2016
Value US$65,762.40 | Price 3.18 | Shares 20,680
Buy 24 Feb 2016
Value US$9,524.70 | Price 3.17 | Shares 3,000
Buy 24 Feb 2016
Value US$221,811.36 | Price 3.18 | Shares 69,752
Buy 24 Feb 2016
Value US$173,154.18 | Price 3.18 | Shares 54,451
Buy 24 Feb 2016
Value US$17,550.42 | Price 3.18 | Shares 5,519
Buy 24 Feb 2016
Value US$20,889.42 | Price 3.18 | Shares 6,569
Buy 24 Feb 2016
Value US$10,217.34 | Price 3.18 | Shares 3,213
Buy 24 Feb 2016
Value US$76,676.16 | Price 3.18 | Shares 24,112
Buy 24 Feb 2016
Value US$75,305.58 | Price 3.18 | Shares 23,681
Buy 24 Feb 2016
Value US$69,829.62 | Price 3.18 | Shares 21,959
Buy 18 Feb 2016
Value US$16,099.50 | Price 3.22 | Shares 5,000
Buy 10 Sep 2015
Value US$23,328.00 | Price 6.48 | Shares 3,600
Buy 10 Sep 2015
Value US$18,208.80 | Price 6.48 | Shares 2,810
Buy 10 Sep 2015
Value US$1,846.80 | Price 6.48 | Shares 285
Buy 10 Sep 2015
Value US$2,196.72 | Price 6.48 | Shares 339
Buy 10 Sep 2015
Value US$1,075.68 | Price 6.48 | Shares 166
Buy 10 Sep 2015
Value US$8,067.60 | Price 6.48 | Shares 1,245
Buy 10 Sep 2015
Value US$7,918.56 | Price 6.48 | Shares 1,222
Buy 10 Sep 2015
Value US$7,341.84 | Price 6.48 | Shares 1,133
Buy 9 Sep 2015
Value US$575.00 | Price 5.75 | Shares 100
Buy 9 Sep 2015
Value US$448.50 | Price 5.75 | Shares 78
Buy 9 Sep 2015
Value US$46.00 | Price 5.75 | Shares 8
Buy 9 Sep 2015
Value US$51.75 | Price 5.75 | Shares 9
Buy 9 Sep 2015
Value US$28.75 | Price 5.75 | Shares 5
Buy 9 Sep 2015
Value US$201.25 | Price 5.75 | Shares 35
Buy 9 Sep 2015
Value US$195.50 | Price 5.75 | Shares 34
Buy 9 Sep 2015
Value US$178.25 | Price 5.75 | Shares 31
Buy 9 Sep 2015
Value US$33,632.94 | Price 5.84 | Shares 5,764
Buy 9 Sep 2015
Value US$21,311.32 | Price 5.03 | Shares 4,236
Buy 9 Sep 2015
Value US$47,860.00 | Price 4.79 | Shares 10,000
Buy 10 Feb 2015
Value US$1,000,000.00 | Price 10.00 | Shares 100,000
Buy 10 Feb 2014
Value US$2,750,000.00 | Price 10.00 | Shares 275,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-03-07 2016-03-04 B Purchase GEARING DAVID

CHIEF SCIENTIFIC OFFICER

Officer
9,966 -43.8%
322.37
US$1,317,650 		9,966 -43.8% 322.37 US$1,317,650
2016-03-17 2016-03-03 S Sale Farrell Geraldine T

VP Operations, General Counsel

Officer
50,917 -26.9%
367.87
US$4,818,671 		50,917 -26.9% 367.87 US$4,818,671
2016-03-07 2016-03-03 B Purchase GEARING DAVID

CHIEF SCIENTIFIC OFFICER

Officer
69,006 -49.4%
356.41
US$3,832,491 		69,006 -49.4% 356.41 US$3,832,491
2016-03-03 2016-03-02 B Purchase Hanna Ashraf Non-Executive Director
1,500 +inf%
3.20
US$4,800 		1,500 +inf% 3.20 US$4,800
2016-03-01 2016-02-26 B Purchase GEARING DAVID

Chief Scientific Officer

Officer
12,126 +11.8%
3.34
US$40,501 		12,126 +11.8% 3.34 US$40,501
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
9,554 +0.4%
3.36
US$32,101 		9,554 +0.4% 3.36 US$32,101
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
7,458 +0.4%
3.36
US$25,059 		7,458 +0.4% 3.36 US$25,059
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
756 +0.4%
3.36
US$2,540 		756 +0.4% 3.36 US$2,540
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
900 +0.4%
3.36
US$3,024 		900 +0.4% 3.36 US$3,024
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
440 +0.4%
3.36
US$1,478 		440 +0.4% 3.36 US$1,478
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
3,303 +0.4%
3.36
US$11,098 		3,303 +0.4% 3.36 US$11,098
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
3,244 +0.4%
3.36
US$10,900 		3,244 +0.4% 3.36 US$10,900
2016-02-26 2016-02-26 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
3,007 +0.4%
3.36
US$10,104 		3,007 +0.4% 3.36 US$10,104
2016-03-01 2016-02-25 B Purchase GEARING DAVID

Chief Scientific Officer

Officer
19,000 +22.7%
3.30
US$62,700 		19,000 +22.7% 3.30 US$62,700
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
65,694 +2.6%
3.18
US$208,907 		65,694 +2.6% 3.18 US$208,907
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
51,283 +2.6%
3.18
US$163,080 		51,283 +2.6% 3.18 US$163,080
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
5,198 +2.6%
3.18
US$16,530 		5,198 +2.6% 3.18 US$16,530
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
6,187 +2.6%
3.18
US$19,675 		6,187 +2.6% 3.18 US$19,675
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
3,026 +2.6%
3.18
US$9,623 		3,026 +2.6% 3.18 US$9,623
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
22,710 +2.6%
3.18
US$72,218 		22,710 +2.6% 3.18 US$72,218
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
22,304 +2.6%
3.18
US$70,927 		22,304 +2.6% 3.18 US$70,927
2016-02-26 2016-02-25 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
20,680 +2.6%
3.18
US$65,762 		20,680 +2.6% 3.18 US$65,762
2016-02-26 2016-02-24 B Purchase Kilty Cormac G Non-Executive Director
3,000 +2.1%
3.17
US$9,525 		3,000 +2.1% 3.17 US$9,525
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
69,752 +2.8%
3.18
US$221,811 		69,752 +2.8% 3.18 US$221,811
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
54,451 +2.8%
3.18
US$173,154 		54,451 +2.8% 3.18 US$173,154
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
5,519 +2.8%
3.18
US$17,550 		5,519 +2.8% 3.18 US$17,550
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
6,569 +2.8%
3.18
US$20,889 		6,569 +2.8% 3.18 US$20,889
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
3,213 +2.8%
3.18
US$10,217 		3,213 +2.8% 3.18 US$10,217
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
24,112 +2.8%
3.18
US$76,676 		24,112 +2.8% 3.18 US$76,676
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
23,681 +2.8%
3.18
US$75,306 		23,681 +2.8% 3.18 US$75,306
2016-02-26 2016-02-24 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
21,959 +2.8%
3.18
US$69,830 		21,959 +2.8% 3.18 US$69,830
2016-02-22 2016-02-18 B Purchase Lismore Damian T.

Chief Financial Officer

Officer
5,000 +36.4%
3.22
US$16,100 		5,000 +36.4% 3.22 US$16,100
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
3,600 +0.1%
6.48
US$23,328 		3,600 +0.1% 6.48 US$23,328
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
2,810 +0.1%
6.48
US$18,209 		2,810 +0.1% 6.48 US$18,209
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
285 +0.1%
6.48
US$1,847 		285 +0.1% 6.48 US$1,847
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
339 +0.1%
6.48
US$2,197 		339 +0.1% 6.48 US$2,197
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
166 +0.1%
6.48
US$1,076 		166 +0.1% 6.48 US$1,076
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
1,245 +0.1%
6.48
US$8,068 		1,245 +0.1% 6.48 US$8,068
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
1,222 +0.1%
6.48
US$7,919 		1,222 +0.1% 6.48 US$7,919
2015-09-11 2015-09-10 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
1,133 +0.1%
6.48
US$7,342 		1,133 +0.1% 6.48 US$7,342
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
100 +0.0%
5.75
US$575 		100 +0.0% 5.75 US$575
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
78 +0.0%
5.75
US$448 		78 +0.0% 5.75 US$448
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
8 +0.0%
5.75
US$46 		8 +0.0% 5.75 US$46
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
9 +0.0%
5.75
US$52 		9 +0.0% 5.75 US$52
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
5 +0.0%
5.75
US$29 		5 +0.0% 5.75 US$29
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
35 +0.0%
5.75
US$201 		35 +0.0% 5.75 US$201
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
34 +0.0%
5.75
US$196 		34 +0.0% 5.75 US$196
2015-09-11 2015-09-09 B Purchase Gunn George W Non-Executive Director
5,764 +102.3%
5.84
US$33,633 		5,764 +102.3% 5.84 US$33,633
2015-09-11 2015-09-09 B Purchase FARALLON CAPITAL MANAGEMENT LLC Large shareholder
31 +0.0%
5.75
US$178 		31 +0.0% 5.75 US$178
2015-09-11 2015-09-09 B Purchase Gunn George W Non-Executive Director
4,236 +302.6%
5.03
US$21,311 		4,236 +302.6% 5.03 US$21,311
2015-09-11 2015-09-09 B Purchase Kilty Cormac G Non-Executive Director
10,000 +7.6%
4.79
US$47,860 		10,000 +7.6% 4.79 US$47,860
2015-02-10 2015-02-10 B Purchase ONE FUNDS MANAGEMENT LTD ATF ASIA PACIFIC HEALTHCARE FUND II Large shareholder
100,000 +12.9%
10.00
US$1,000,000 		100,000 +12.9% 10.00 US$1,000,000
2015-02-10 2014-02-10 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
275,000 +inf%
10.00
US$2,750,000 		275,000 +inf% 10.00 US$2,750,000
Explore more

More insider trading research around Nexvet Biopharma plc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America